Search

Search Constraints

You searched for: Author/Creator Connors, Joseph M.

Search Results

2. Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphoma. (16th December 2016)

3. Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation. (6th October 2019)

4. Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study. Issue 2 (16th February 2021)

5. Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. Issue 9 (20th June 2016)

7. Comparison of the NCCN‐IPI, the IPI and PIT scores as prognostic tools in peripheral T‐cell lymphomas. (11th March 2019)

9. Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status. Issue 3 (3rd March 2016)

10. Diffuse large B‐cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era. (14th October 2016)